Edward Ronan |

Edward Ronan

Patent Attorney

Edward is a Chartered Patent Attorney and European Patent Attorney in the Biotechnology and Life Sciences Group.

Edward is experienced in the preparation and prosecution of patent applications in the UK, Europe and worldwide. He regularly assists clients with managing global patent portfolios and providing commercial advice, including the preparation of freedom-to-operate opinions and has assisted in diligence exercises.

Edward completed a doctorate at the University of Oxford on the role of local immunity in vaccine-induced protection against tuberculosis. His work specifically investigated the immunological effects of delivering adenoviral and protein based vaccines to the respiratory tract.

Edward was awarded the Strode Prize for the highest mark in the legal paper of the
2014 UK patent finals examinations.

Recent work

Advised a bio venture capital company on due diligence and freedom-to-operate issues related to a university spinout.
Assisted a major pharmaceutical company with the drafting of a portfolio of patent applications in a new therapeutic area.
Manages the European and foreign patent portfolio for a medium sized pharmaceutical and diagnostics company based in the UK.

Publications

'boult.bites Biotech, Spring edition'. April 2017

'boult.bites Biotech, Autumn edition'. October 2016

'boult.bites Biotech, Spring edition'. April 2016

'boult.bites Biotech', Ocotber 2015

'Aligning patent strategy and commercial aims in life sciences', Biotech and Money, November 2017

'UK High Court provides guidance on SPCs based on Markush claims', May 2017

'Landmark case awards first Arrow/Fujifilm declaration', March 2017

'Experimental models in patents - what is "plausible"?', March 2016

'Essentially Biological Products - EPO decides on Broccoli and Tomato II', May 2015

'Essentially Biological Products? - Broccoli II', October 2013

'Gene patents in the US - The Supreme Court decides on Myriad', June 2013